UpHealth Group Limited

UpHealth Group Limited

SSGX:GRQ
0.13
SGD
0.00
(0.00%)
19.39MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.21
0.15
0.16
0.24
0.21
0.21
0.25
- -
- -
- -
- -
Basic EPS, GAAP
- -
0.03
0.03
0.04
0.03
0.06
0.07
-0.01
-0.03
-0.15
-0.01
- -
Free Cash Flow per Basic Share
- -
0.09
-0.04
0.01
0.06
0.01
-0.01
-0.02
0.01
-0.08
-0.04
- -
Dividend per Share
- -
- -
- -
- -
- -
0.01
0.02
- -
- -
- -
- -
- -
Book Value per Share
0.08
0.13
0.18
0.2
0.25
0.29
0.45
0.48
0.38
0.34
0.45
0.41
Tangible Book Value per Share
0.08
0.13
0.18
0.2
0.25
0.29
0.45
0.48
0.38
0.34
0.45
-0.1
Basic Weighted Avg Shares
150
150
150
150
150
148
150
150
150
150
150
150
Sales/Revenue/Turnover
- -
31
23
24
35
31
31
38
- -
- -
- -
- -
Operating Margin (%)
- -
21.39
22.68
30.04
16.89
32.1
29.95
-0.66
- -
- -
- -
- -
Depreciation Expense
- -
2
2
2
2
2
3
4
3
2
- -
- -
Net Income, GAAP
- -
4
4
6
5
9
10
-2
-4
-23
-1
- -
Effective Tax Rate (%)
- -
3.04
1.87
0.84
5.48
3.5
2.64
- -
- -
- -
- -
- -
Profit Margin (%)
- -
13.68
17.68
26.21
14.74
28.06
33.35
-5.23
- -
- -
- -
- -
Working Capital
5
13
7
12
17
23
26
21
14
51
67
4
LT Debt
9
12
- -
1
5
6
6
5
5
- -
- -
55
Total Equity
12
20
27
29
37
43
68
73
57
52
67
61
Return on Invested Capital (%)
- -
18.31
12.87
17.58
13.65
17.78
16.07
- -
- -
- -
- -
- -
Return on Capital (%)
- -
21.14
14.34
19.01
15.18
18.96
16.92
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
26.65
17.4
22.46
15.62
21.52
18.6
-2.83
-6.57
-41.68
-2.3
- -

Capital Structure

SGD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
- -
8
LT Borrowings
- -
- -
32
LT Finance Leases
- -
- -
23
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
150
150
150
Market Capitalization
26
20
19

Working Capital

SGD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
69
68
24
Cash, Cash Equivalents & STI
25
25
18
Accounts Receivable, Net
- -
- -
1
Inventories
- -
- -
3
Total Current Liabilities
2
2
20
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
8
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.42%
12.55%
30.21%
Free Cash Flow
- -
-280.88%
-47.97%
Net Income, GAAP
- -
70.51%
-93.98%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.15
2025
- -
- -
-0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Marat Devlet-Kildeyev
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
Municipal District Marfino Russian Federation
IPO Date
Feb 14, 2020
Business
UpHealth Group Limited is a Singapore-based healthcare holding company specializing in the provision of advanced oncology treatment, cancer diagnostics, and multifunctional medical services. The company operates a network of specialized private medical centers primarily under the Euroonco and Uni Medica (Uni Clinic) brands, serving oncology patients and general medical consumers. Its portfolio of clinical services includes specialized oncology consultations and multidisciplinary tumor board reviews; systemic cancer therapies, including chemotherapy, immunotherapy, targeted therapy, and hormone therapy; interventional oncology procedures, including chemoembolization and tumor ablation; surgical oncology and complex minimally invasive surgical interventions; supportive and palliative care, pain management, and symptomatic treatment for advanced-stage cancer patients; comprehensive diagnostic imaging services, including computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound; endoscopic examinations and histological biopsies; molecular genetic profiling and comprehensive laboratory diagnostics; intensive care unit (ICU) and inpatient hospitalization services; and multidisciplinary outpatient medical consultations, day surgery, and post-operative rehabilitation. Headquartered in Singapore, the company was incorporated in 2018 and conducts its medical operations across key metropolitan centers in the Russian Federation, including Moscow, Saint Petersburg, Krasnodar, Samara, and Nizhny Novgorod. The group recently underwent a comprehensive strategic reorganization and corporate transformation, pivoting its core business model from commercial agriculture to specialized healthcare services. In January 2026, the company secured shareholder approval to diversify into the medical sector, completed the acquisition of healthcare operating assets comprising the Euroonco oncology clinic network and the Uni Medica multifunctional medical facility, and officially changed its corporate name from Don Agro International Limited to UpHealth Group Limited. Following the divestment of its legacy agricultural assets in Russia, which previously engaged in crop cultivation and raw milk production, the company is focusing its strategic initiatives on integrating acquired healthcare facilities, expanding specialized oncology bed and surgical capacities, and introducing standardized clinical diagnostic and treatment protocols across its regional medical network.